Analytical Chemistry,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 30, 2024
Mitochondrial
polarity
is
a
critical
indicator
of
numerous
pathological
and
biological
processes;
thus,
the
development
fluorescent
probes
capable
targeting
mitochondria
visually
monitoring
its
great
significance.
In
this
study,
were
designed
with
N,
N-dialkylamino
rhodol
scaffold
as
fluorophore
sensitive
to
environments,
in
which
alkyl
chain
length
was
adjusted
rationally
obtain
distinct
recognition
modes.
By
integrating
groups,
three
fluorogenic
chemical
Chemical Reviews,
Год журнала:
2024,
Номер
124(5), С. 2699 - 2804
Опубликована: Фев. 29, 2024
The
ability
to
gain
spatiotemporal
information,
and
in
some
cases
achieve
control,
the
context
of
drug
delivery
makes
theranostic
fluorescent
probes
an
attractive
intensely
investigated
research
topic.
This
interest
is
reflected
steep
rise
publications
on
topic
that
have
appeared
over
past
decade.
Theranostic
probes,
their
various
incarnations,
generally
comprise
a
fluorophore
linked
masked
drug,
which
released
as
result
certain
stimuli,
with
both
intrinsic
extrinsic
stimuli
being
reported.
release
then
signaled
by
emergence
signal.
Importantly,
use
appropriate
fluorophores
has
enabled
not
only
this
emerging
fluorescence
marker
for
but
also
provided
modalities
useful
photodynamic,
photothermal,
sonodynamic
therapeutic
applications.
In
review
we
highlight
recent
work
particular
focus
are
activated
tumor
microenvironments.
We
summarize
efforts
develop
other
applications,
such
neurodegenerative
diseases
antibacterials.
celebrates
diversity
designs
reported
date,
from
discrete
small-molecule
systems
nanomaterials.
Our
aim
provide
insights
into
potential
clinical
impact
still-emerging
direction.
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(9)
Опубликована: Янв. 18, 2024
Although
the
clearance
of
senescent
cells
has
been
proven
to
slow
down
aging
process
and
promote
anti-cancer
chemotherapy,
development
senolytics
remains
challenging.
Herein,
we
report
a
senolytic
strategy
enabled
by
cell-sensitive
bioorthogonal
tetrazine
ligation.
Our
design
is
based
on
linking
dihydrotetrazine
(Tz)
galactose
(Gal)
moiety
that
serves
both
as
recognition
for
senescence-associated
β-galactosidase
caging
group
control
activity.
Gal-Tz
enables
efficient
click-release
fluorescent
hemicyanine
doxorubicin
from
trans-cyclooctene-caged
prodrug
detect
eliminate
HeLa
A549
over
non-senescent
counterparts
with
16.44
index.
Furthermore,
leverage
selective
activation
delivery
proteolysis-targeting
chimeras
(PROTACs)
senolytics.
PROTAC
TCO-ARV-771
can
be
selectively
activated
delivered
into
induce
degradation
bromodomain-containing
protein
4.
Senolytic
PROTACs
may
offer
an
way
intervention
cell
senescence
thanks
their
unique
capacity
degrade
target
proteins
in
sub-stoichiometric
catalytic
fashion.
The
results
this
study
establish
ligation
approach
viable
removal
cells.
Journal of Medicinal Chemistry,
Год журнала:
2024,
Номер
67(9), С. 7301 - 7311
Опубликована: Апрель 18, 2024
Although
the
selective
and
effective
clearance
of
senescent
cancer
cells
can
improve
treatment,
their
development
is
confronted
by
many
challenges.
As
part
efforts
designed
to
overcome
these
problems,
prodrugs,
whose
design
based
on
senescence-associated
β-galactosidase
(SA-β-gal),
have
been
developed
selectively
eliminate
cells.
However,
chemotherapies
relying
targeted
molecular
inhibitors
as
senolytic
drugs
induce
drug
resistance.
In
current
investigation,
we
devised
a
new
strategy
for
degradation
target
proteins
in
that
utilizes
prodrug
composed
SA-β-gal
substrate
galactose
(galacto)
proteolysis-targeting
chimeras
(PROTACs)
agents.
Prodrugs
Gal-ARV-771
Gal-MS99
were
found
display
indexes
higher
than
those
ARV-771
MS99.
Significantly,
results
vivo
studies
utilizing
human
lung
A549
xenograft
mouse
model
demonstrated
concomitant
treatment
with
etoposide
leads
significant
inhibition
tumor
growth
without
eliciting
toxicity.
Analytical Chemistry,
Год журнала:
2024,
Номер
96(29), С. 12189 - 12196
Опубликована: Июль 8, 2024
Aging
represents
a
significant
risk
factor
for
compromised
tissue
function
and
the
development
of
chronic
diseases
in
human
body.
This
process
is
intricately
linked
to
oxidative
stress,
with
HClO
serving
as
vital
reactive
oxygen
species
(ROS)
within
biological
systems
due
its
strong
properties.
Hence,
conducting
thorough
examination
context
aging
crucial
advancing
field
biology.
In
this
work,
we
successfully
developed
fluorescent
probe,
OPD,
tailored
specifically
detecting
senescent
cells
vivo.
Impressively,
OPD
exhibited
robust
reaction
HClO,
showcasing
outstanding
selectivity,
sensitivity,
photostability.
Notably,
effectively
identified
first
time,
confirming
that
DOX-
ROS-induced
higher
levels
compared
uninduced
normal
cells.
Additionally,
vivo
imaging
zebrafish
demonstrated
d-galactose-
ROS-stimulated
displayed
elevated
zebrafish.
Furthermore,
when
applied
mouse
tissues
organs,
revealed
increased
fluorescence
organs
mice
their
nonsenescent
counterparts.
Our
findings
also
illustrated
probe's
potential
changes
content
pre-
post-aging
living
mice.
Overall,
probe
holds
immense
promise
valuable
tool
detection
studying
biology
live
organisms.
Angewandte Chemie International Edition,
Год журнала:
2023,
Номер
63(6)
Опубликована: Окт. 19, 2023
Abstract
Activatable
fluorescent
and
chemiluminescent
dyes
with
near‐infrared
emission
have
indispensable
roles
in
the
fields
of
bioimaging,
molecular
prodrugs,
phototheranostic
agents.
As
one
most
popular
fluorophore
scaffolds,
dicyanomethylene‐4
H
‐pyran
scaffold
has
been
applied
to
fabricate
a
large
number
versatile
activatable
optical
for
analytes
detection
diseases
diagnosis
treatment
by
virtue
its
high
photostability,
Stokes
shift,
considerable
two‐photon
absorption
cross‐section,
structural
modifiability.
This
review
discusses
design
strategies,
recognition
mechanisms,
both
vitro
vivo
bio‐applications
(especially
therapy
tumors)
dyes.
The
final
section
describes
current
shortcomings
future
development
prospects
this
topic.
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Май 26, 2024
Cellular
senescence
is
a
significant
risk
factor
for
aging
and
age-related
diseases
(ARD).
The
canonical
senolytics
Dasatinib
Quercetin
(DQ)
have
shown
promise
in
clearing
senescent
cells
(SnCs);
however,
the
lack
of
selectivity
poses
challenge
achieving
optimal
outcomes.
Despite
recent
occurrence
nanomaterial-based
approaches
targeting
SnCs,
limited
therapeutic
effects,
potential
toxicity
still
remain
major
concern.
Herein,
"double
locks-like"
nanoplatform
developed
that
integrated
Galactan
coating
mesoporous
polydopamine
to
encase
senolytic
drug
DQ.
By
this
way,
DQ
only
released
SnCs
are
featured
with
higher
levels
β-galactosidase
(β-gal)
low
PH.
Additionally,
nanoparticles
equipped
2,2,6,6-Tetramethylpiperidine-1-oxyl
(Tempo)
gain
enhanced
photothermal
converting
potential.
Consequently,
synthesized
nanosenolytics
demonstrate
remarkable
specificity
efficacy
eradicating
accordingly
reverse
pulmonary
fibrosis
mice
without
affecting
normal
tissues.
Upon
exposure
near-infrared
(NIR)
light,
efficiently
remove
tumor
inducted
by
chemotherapy,
thereby
hindering
outgrowth
metastasis
or
breast
cancer.
Collectively,
present
study
develops
an
"On/Off"
switchable
response
produces
more
safe,
efficient,
feasible
way
delay
alleviate
age-associated
diseases.
Journal of Translational Internal Medicine,
Год журнала:
2025,
Номер
13(1), С. 33 - 47
Опубликована: Фев. 1, 2025
Aging
and
age-related
diseases
are
major
drivers
of
multimorbidity
mortality
worldwide.
Cellular
senescence
is
a
hallmark
aging.
The
accumulation
senescent
cells
causally
associated
with
pathogenesis
various
age-associated
disorders.
Due
to
their
promise
for
alleviating
disorders
extending
healthspan,
therapeutic
strategies
targeting
(senotherapies)
as
means
combat
aging
have
received
much
attention
over
the
past
decade.
Among
conventionally
used
approaches,
one
usage
small-molecule
compounds
specifically
exhibit
cytotoxicity
toward
or
inhibit
deleterious
effects
senescence-associated
secretory
phenotype
(SASP).
Alternatively,
there
immunotherapies
directed
at
surface
antigens
upregulated
in
(seno-antigens),
including
chimeric
antigen
receptor
(CAR)
therapies
senolytic
vaccines.
This
review
gives
an
update
current
status
discovery
development
therapies,
translational
progress
from
preclinical
clinical
trials.
We
highlight
challenges
faced
by
senotherapeutic
context
heterogeneity,
aim
offering
novel
perspectives
future
anti-aging
interventions
aimed
enhancing
healthy
longevity.